pubmed· e01.org

PubMed · PMID 10944864

Current and future trends in transfusion therapy.

PMID 10944864Journal Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology NursesYear 2000Authors 2DOI 10.1053/jpon.2000.8064

  • Source PubMed
  • Journal Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
  • Year 2000
  • Authors C L Rossetto; J E McMahon
  • Licence NLM/PubMed terms

Abstract

The increase in intensive treatment for cancer has impacted blood product transfusion practices. Transfusion guidelines are primarily institution specific, but the general concepts and theories are universal. Blood product screening has decreased the risk of transfusion-acquired infections; however, the risk is not obsolete. This article reviews current approaches to platelet, white blood cell, and red blood cell transfusions, as well as risks associated with these therapies (e.g., infection and transfusion-associated graft-versus-host disease). Pertinent laboratory studies, patient assessment, blood product administration, and patient education is discussed.

The current approaches to platelet, white blood cell, and red blood cell transfusions are constantly changed and evaluated. Pediatric oncology nurses must stay up to date with these changes to provide optimal patient care.

Record details

PMID10944864
PMCIDnot held
DOI10.1053/jpon.2000.8064
JournalJournal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
Year2000
AuthorsC L Rossetto; J E McMahon
Licencenot stated
MeSHBlood Component Transfusion; Humans; Neoplasms; Oncology Nursing; Pediatric Nursing; Practice Guidelines as Topic

Source record

Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.

Source
PubMed / NLM
PMID
10944864
Rendered
2026-11-22
Completeness
abstract and citation fields